Alpha Cognition Inc. Cash and Restricted Cash
Alpha Cognition Inc. (ACOG) had Cash and Restricted Cash of $41.44 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $41.44M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $54.31M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $66.11M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $35.46M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $41.44M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $54.31M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $66.11M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $35.46M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $39.46M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $45.62M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $48.56M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $3.77M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $1.19M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $2.42M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $1.49M 10-K · filed 2026-03-31 |
| 2023-09-30 | $908.36K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $1.22M 10-Q · filed 2024-08-12 |
| 2022-12-31 | $2.08M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |